Atıf Formatları
Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. Alkan Et Al. , "Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers," FDI 2017, WORLD DENTAL CONGRESS , vol.67, no.1, Madrid, Spain, pp.148, 2017

Alkan, Ö. Et Al. 2017. Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers. FDI 2017, WORLD DENTAL CONGRESS , (Madrid, Spain), 148.

Alkan, Ö., Kaya, Y., Ayhan Alkan, E., Alpaslan Yaylı, N. Z., & Keskin, S., (2017). Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers . FDI 2017, WORLD DENTAL CONGRESS (pp.148). Madrid, Spain

Alkan, Özer Et Al. "Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers," FDI 2017, WORLD DENTAL CONGRESS, Madrid, Spain, 2017

Alkan, Özer Et Al. "Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers." FDI 2017, WORLD DENTAL CONGRESS , Madrid, Spain, pp.148, 2017

Alkan, Ö. Et Al. (2017) . "Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers." FDI 2017, WORLD DENTAL CONGRESS , Madrid, Spain, p.148.

@conferencepaper{conferencepaper, author={Özer Alkan Et Al. }, title={Interleukin-1ß And Prostaglandin E2 Levels During FixedOrthodontic Treatment in Smokers Versus Non-Smokers}, congress name={FDI 2017, WORLD DENTAL CONGRESS}, city={Madrid}, country={Spain}, year={2017}, pages={148} }